Article Details
Retrieved on: 2019-01-11 05:12:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Sofinnova Ventures</b> Inc bought a new position in Entasis Therapeutics in the 3rd quarter valued at $12,840,000. Institutional investors own ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here